Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $IDRA IDERA PHARMACEUTICALS, INC.
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 11,175,900 shares
Current Value: $17,434,404
Latest Transaction: Aug 17 2006
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in IDERA PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, AUXL, GHDX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 4,935,126 | 3,207,832 | 8,381,925 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 608,343 | 395,423 | 0 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 505,590 | 328,634 | 0 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Option Exercise | J | 0.65 | 3,821,193 | 2,483,775 | 0 | |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | J | 0.00 | 6,580,168 | 0 | 11,175,900 | 4.6 M to 11.2 M (+143.18 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 811,124 | 0 | 0 | 811.1 K to 0 (-100.00 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 674,120 | 0 | 0 | 674.1 K to 0 (-100.00 %) |
| Aug 17 2006 | IDRA | IDERA PHARMACEUTIC ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | J | 0.00 | 5,094,924 | 0 | 0 | 5.1 M to 0 (-100.00 %) |
Page: 1